Delivery Order SPE2DR25D3003-SPE2DR26F5RY7
Award Date 3/26/26
Potential Completion Date 4/16/26
Potential Value $7.8K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $38,970.50 delivery order to AmerisourceBergen Drug Corp on March 10, 2026, for IMBRUVICA 420 MG tablets (28-count), with an ultimate completion date of March 31, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which provides comprehensive pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken,...
- The Defense Logistics Agency issued a $31,176.40 delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for supply of Imbruvica 420 mg tablets (28-count units). This order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which serves as the global pharmaceutical supply vehicle for military healthcare programs. The contract is firm fixed price with no set-aside. Place of performance is Conshohocken, PA....
- The Defense Logistics Agency issued a $46,764.60 delivery order to AmerisourceBergen Drug Corp on March 24, 2026, for IMBRUVICA 420 mg tablets (28-count units). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), a $999,999,999 vehicle extending through December 2026 that supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, PA. The order carries firm fixed pricing with...
- The Defense Logistics Agency issued a $7,794.10 delivery order to Amerisourcebergen Drug Corp on March 24, 2026, for IMBRUVICA 420 MG tablet supply (28-count units). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) with Cencora, Inc. (parent of Amerisourcebergen Drug Corp), a $999,999,999 vehicle running through December 2026 that supplies pharmaceutical products and medical supplies globally to military healthcare systems. Place of performance is...
- The Defense Logistics Agency issued a $8,351.42 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for IMBRUVICA 140 MG capsules (90 count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at $999,999,999.00 through December 2026, which provides pharmaceutical and medical supply support to military healthcare systems globally. Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 10, 2026, for IMBRUVICA 420 mg tablets (28-count) with a ceiling value of $7,794.10 under firm fixed-price pricing. Place of performance is Conshohocken, PA 19428. The order is due for ultimate completion on March 31, 2026. No set-aside was used. The delivery order is issued under the parent DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 and extending through...
- The Defense Logistics Agency issued a $31,176.40 delivery order to Amerisourcebergen Drug Corp on March 23, 2026, for supply of Imbruvica 420 mg tablets. This delivery order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), a global pharmaceutical support vehicle enabling supply of a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Place of performance...
- <p>The Defense Logistics Agency issued a $31,176.40 delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for IMBRUVICA 420 mg tablets (28-count units), with ultimate completion by March 25, 2026.</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.</p>
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 6, 2026, with a ceiling value of $15,586.54 for the supply of IMBRUVICA 280MG 28S pharmaceutical product, with a final completion date of March 27, 2026. This order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued up to $999,999,999.00 through December 2026), which serves as a global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical...
- The Defense Logistics Agency issued a $16,702.86 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for IMBRUVICA 140MG 90S (imbruvica 140 milligram 90-count tablets), with an ultimate completion date of March 27, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...